KOREY ANGLIN: Open Payments
NPI 1164094611 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 31 payments from 11 companies in 2025. Trend: 2023 $362 · 2024 $591 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 9 | $158 |
| Novartis Pharmaceuticals Corporation | 4 | $147 |
| Calliditas Therapeutics US Inc. | 4 | $111 |
| Ardelyx, Inc. | 4 | $80 |
| AKEBIA THERAPEUTICS INC | 3 | $78 |
| SCPHARMACEUTICALS INC. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Stryker Corporation | 1 | $27 |
| Vifor Pharma, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $24 |
Products named: VELPHORO, Fabhalta, TARPEYO, IBSRELA, Auryxia, FUROSCIX, JYNARQUE, Vafseo.
Industry payments across FL — which companies pay providers there.
